The photothrombotic (PT) model of ischemic stroke is induced by local intravascular photooxidation. The procedure relies on the intraperitoneal (mice) or intravenous (rats and large animals) administration of a light-sensitive dye, and then shining specific wavelengths of light through the intact skull to the brain. Light activates the dye, leading to the formation of singlet oxygen and superoxide, which in turn leads to endothelial damage, platelet activation, and aggregation. This results in rapid ischemic cell death in illuminated brain regions in the arterial terminal region, ultimately leading to cortical ischemic lesions.
Fig. 1. The development of photothrombotic lesion. (Verma et al., 2021)
Ace Therapeutics provides state-of-the-art photothrombotic stroke models to study the molecular mechanisms of ischemic cell death and search potential anti-stroke drugs. With our expertise in this field, we provide customized and reliable solutions to meet the unique needs of our clients.
We can inject Rose Bengal (4,5,6,7-tetrachloro-2',4',5',7'-tetraiodoluciferin) into rodents and enters to the bloodstream. The target brain region is irradiated with a specific wavelength of light to trigger the coagulation cascade and lead to thrombus formation.
We have strict quality control systems for the concentration of sensitive dyes, the delay time between dye injection and irradiation, the intensity of the light source, the diameter of the illuminated surface, the irradiation time, and body temperature during and after surgery. We can perform a series of preliminary experiments to test reproducibility and determine the minimum dye amount and irradiation time to produce a lesion that selectively affects the target area and/or obtains significant behavioral deficits.
Ace Therapeutics offers customers worldwide a customizable, easy-to-execute, and highly reproducible photothrombotic stroke model that helps you assess cortical plasticity in response to brain injury at the cellular and molecular levels. With superior solutions and an experienced team, we are your ideal partner for stroke research. Clients can contact us directly and receive timely feedback.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.